Novel Drug Impresses in Postpartum Depression Phase 3 Trial Novel Drug Impresses in Postpartum Depression Phase 3 Trial

Women with postpartum depression may experience significant reductions in symptoms after just 3 days of taking a novel neuroactive steroid, new research suggests.Medscape Medical News
Source: Medscape Psychiatry Headlines - Category: Psychiatry Tags: Psychiatry News Source Type: news